Paper Tigers Or Paper Bullets? FDA Cutting Down On Repeat GMP Warnings
This article was originally published in The Tan Sheet
Executive Summary
FDA enforcement policies being carried out by the Office of the Chief Counsel could eliminate the practice of issuing multiple manufacturing compliance warning letters